FLUCELVAX QUADRIVALENT

This brand name is authorized in United States. It is also authorized in Canada.

Active ingredients

The drug FLUCELVAX QUADRIVALENT contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII EZQ32TF2AS - INFLUENZA A VIRUS A/NEBRASKA/14/2019 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
 
Read more about Influenza, inactivated, surface antigen
2
UNII 5MIR93VLG8 - INFLUENZA A VIRUS A/DELAWARE/39/2019 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
 
Read more about Influenza, inactivated, surface antigen
3
UNII G4VX46P9M6 - INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
 
Read more about Influenza, inactivated, surface antigen
4
UNII ZBC2SPA9BZ - INFLUENZA B VIRUS B/DARWIN/7/2019 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
 
Read more about Influenza, inactivated, surface antigen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J07BB02 Influenza, purified antigen J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BB Influenza vaccines
Discover more medicines within J07BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
CA Health Products and Food Branch 02494248
US FDA, National Drug Code 70461-320, 70461-420

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈